Clevexel Pharma Is A Pharmaceutical Company Based In Parisfounded In 2013The Company Focuses On The Early Stage Development Of Innovative Therapeutic Solutions To Address Unmet Patient Needsclevexel Pharma Employs A Unique Business Model That Involves Selecting Promising Molecules For Investment And Developmentoften Collaborating With Partners To Enhance The Marketing Potential Of These Molecules The Primary Service Offered By Clevexel Pharma Is The Design And Early Development Of Treatmentsthe Company Advances High Potential Projects To The Clinical Proof Of Concept Stageacting As A Bridge Between Early Stage Research And Larger Pharmaceutical Companiesnotable Projects Include Cvxl 0095Aimed At Reducing Mucositis Or Dermatitisand Cvxl 0255Which Targets Immuno Inflammatory Processesclevexel Pharma Also Has A History Of Focusing On Central Nervous System Disordersparticularly Those Related To Movement Disordersthe Company Is Led By Ceo And Founder Christian Bloy And Employs Around 15 People
